These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Peripheral neuropathy unmasked by therapy with adrenal cortex hormones during myalgia-eosinophilia syndrome related to L-tryptophan]. Moreaud O; Mezin P; De Saint Victor JF; Noelle B; Berger F; Pellat J Presse Med; 1994 Jun; 23(24):1138. PubMed ID: 7971839 [No Abstract] [Full Text] [Related]
29. Head and neck manifestations of eosinophilia-myalgia syndrome. Levine B; Lanza DC; Ficco A; Freundlich B Ann Otol Rhinol Laryngol; 1995 Feb; 104(2):90-9. PubMed ID: 7857025 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of L-tryptophan eosinophilia myalgia syndrome. Sternberg EM Adv Exp Med Biol; 1996; 398():325-30. PubMed ID: 8906284 [TBL] [Abstract][Full Text] [Related]
31. L-tryptophan and eosinophilia-myalgia syndrome. Shapiro S Lancet; 1994 Sep; 344(8925):817-9. PubMed ID: 7916094 [No Abstract] [Full Text] [Related]
32. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion. Beko E; Pervaiz S; Nanda V; Dhawan S Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608 [TBL] [Abstract][Full Text] [Related]
33. L-tryptophan and eosinophilia-myalgia syndrome. Shapiro S Lancet; 1994 Apr; 343(8904):1035-7. PubMed ID: 7909063 [No Abstract] [Full Text] [Related]
39. Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome. Johnson KL; Klarskov K; Benson LM; Williamson BL; Gleich GJ; Naylor S J Rheumatol; 1999 Dec; 26(12):2714-7. PubMed ID: 10606395 [No Abstract] [Full Text] [Related]
40. The eosinophilia-myalgia syndrome: opportunities realized and missed. Hertzman PA J Rheumatol; 1996 Oct; 23(10):1679-81. PubMed ID: 8895138 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]